Keen Technologies, an artificial general intelligence startup from ex-Oculus CTO John Carmack, raised $20M led by ex-GitHub CEO Nat Friedman and Daniel Gross
Context & Ripple Effects
When John Carmack stepped away from Oculus to found Keen Technologies, the notable thing about its $20M raise was how small it was for an artificial general intelligence ambition — a deliberate bet that a tiny team could outlast the capital-heavy labs. The round also cemented Nat Friedman and Daniel Gross as the go-to operator-investors for founder-led AGI efforts.
The years since have validated both halves of that story in different directions: Gross went on to co-found Safe Superintelligence before departing it, while Friedman now leads the Meta Superintelligence Labs products team — and the funding baseline has shifted entirely, with Humans& raising a $480M seed at a $4.48B valuation.
First-order effects
- Carmack secures multi-year runway for Keen without near-term revenue pressure, keeping the lab independent of the mega-cap funder ecosystem.
- Friedman and Gross convert their operator reputations into equity in a marquee-founder AGI bet, extending the NFDG franchise beyond angel checks into lab-building.
Second-order effects
- The ex-GitHub CEO pipeline now runs both ways — Friedman backed Carmack's lab while fellow former GitHub chief Thomas Dohmke launched Entire's $60M open-source developer-tools seed, making alumni-of-record a repeatable startup template.
- As later AGI entrants priced seeds in the hundreds of millions, Keen's lean-capital thesis became a differentiator rather than a limitation, pressuring rivals to justify burn rates against a two-person-check competitor.
Third-order effects
- If the pattern holds, AGI research consolidates around small teams of famous builders financed by a rotating cast of the same operator-investors — Friedman and Gross appear across the cycle even as their day jobs change — concentrating deal flow and signal in fewer hands.
- The four-year jump from Keen's $20M to comparable nine-figure seeds suggests AGI fundraising is inflating faster than headcount needs, pushing capital toward valuation signaling over research runway.
The trend: Founder-led AGI labs are scaling from tens of millions in early capital to half-billion-dollar seeds within a few years, with a small circle of operator-investors recurring across every cycle.